Add to ORKGistopathology additionally revealed antiangiogenic properties in vivo for UNBS5162 in the orthotopic PC-3 model. In conclusion, the present study reveals UNBS5162 to be a pan-antagonist of CXCL chemokine expression, with t ntal models of human refractory prostate cancer when ad axol when coadministered with the taxoid
In the mid 1990s, researchers began to investigate the antiangiogenic activity of paclitaxel as a po...
Several in vitro and in vivo models have revealed the key role of CXCR4/CXCL12 axis in tumor-stroma ...
We investigated possible cellular receptors for the human CXC chemokine platelet factor-4 variant/CX...
Several naphthalimides have been evaluated clinically as potential anticancer agents. UNBS3157, a na...
AbstractSeveral naphthalimides have been evaluated clinically as potential anticancer agents. UNBS31...
The current study was undertaken to characterize the effect of anti-metabolites on inducing CXCL8 si...
Background: The current study was undertaken to characterize the effect of anti-metabolites on induc...
Chemotherapy of castration resistant prostate cancer (CRPC) is based on taxane formulations worldwid...
CXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful attracta...
AbstractCXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful ...
International audienceThe CXCL4 paralog CXCL4L1 is a less studied chemokine that has been suggested ...
AbstractSeveral in vitro and in vivo models have revealed the key role of CXCR4/CXCL12 axis in tumor...
Several in vitro and in vivo models have revealed the key role of CXCR4/CXCL12 axis in tumor-stroma ...
We investigated possible cellular receptors for the human CXC chemokine platelet factor-4 variant/CX...
The CXCL4 paralog CXCL4L1 is a less studied chemokine that has been suggested to exert an antiangiog...
In the mid 1990s, researchers began to investigate the antiangiogenic activity of paclitaxel as a po...
Several in vitro and in vivo models have revealed the key role of CXCR4/CXCL12 axis in tumor-stroma ...
We investigated possible cellular receptors for the human CXC chemokine platelet factor-4 variant/CX...
Several naphthalimides have been evaluated clinically as potential anticancer agents. UNBS3157, a na...
AbstractSeveral naphthalimides have been evaluated clinically as potential anticancer agents. UNBS31...
The current study was undertaken to characterize the effect of anti-metabolites on inducing CXCL8 si...
Background: The current study was undertaken to characterize the effect of anti-metabolites on induc...
Chemotherapy of castration resistant prostate cancer (CRPC) is based on taxane formulations worldwid...
CXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful attracta...
AbstractCXCL5 is a proangiogenic CXC-type chemokine that is an inflammatory mediator and a powerful ...
International audienceThe CXCL4 paralog CXCL4L1 is a less studied chemokine that has been suggested ...
AbstractSeveral in vitro and in vivo models have revealed the key role of CXCR4/CXCL12 axis in tumor...
Several in vitro and in vivo models have revealed the key role of CXCR4/CXCL12 axis in tumor-stroma ...
We investigated possible cellular receptors for the human CXC chemokine platelet factor-4 variant/CX...
The CXCL4 paralog CXCL4L1 is a less studied chemokine that has been suggested to exert an antiangiog...
In the mid 1990s, researchers began to investigate the antiangiogenic activity of paclitaxel as a po...
Several in vitro and in vivo models have revealed the key role of CXCR4/CXCL12 axis in tumor-stroma ...
We investigated possible cellular receptors for the human CXC chemokine platelet factor-4 variant/CX...